Isoimperatorin CAS: 482-45-1

CAS NO: 482-45-1
Isoimperatorin
Chemical Name: Isoimperatorin
Molecular Formula: C16H14O4
Formula Weight: 270.28
CAS No.: 482-45-1
Description Review
Description

Isoimperatorin is a natural organic compound that is commonly found in plants such as Angelica Dahurica and Peucedanum praeruptorum. Its full chemical name is 1-[(3-Methylbut-2-enyl)oxy]-8-(3-methylpent-2-enyl)-5,6,7,8-tetrahydrocoumarin, and its molecular formula is C16H20O3. It has a molecular weight of 260.33 g/mol and is also known by its CAS number 482-45-1.

This compound has been traditionally used for its medicinal properties in China, Korea, and Japan. In this article, we will explore the top ten keywords associated with isoimperatorin, its health benefits, potential effects, product mechanism, safety, side effects, and dosing information.

Top Ten Keywords and Synonyms

  1. Coumarin derivative
  2. Angelica Dahurica
  3. Peucedanum praeruptorum
  4. Traditional Chinese medicine
  5. Anti-inflammatory
  6. Antioxidant
  7. Neuroprotective
  8. Anti-cancer
  9. Cardiovascular health
  10. Phytochemical

Health Benefits of Isoimperatorin

Research has shown that isoimperatorin may have several potential health benefits. One of the primary benefits of this compound is its anti-inflammatory properties. Studies have suggested that isoimperatorin can reduce inflammation by suppressing pro-inflammatory cytokines and enzymes in the body.

Isoimperatorin has also been found to have antioxidant properties, which can help protect against oxidative stress and damage caused by free radicals. Additionally, this compound has been investigated for its neuroprotective properties, as it may help prevent or slow down the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.

Studies have also suggested that isoimperatorin may have anti-cancer properties, particularly in the treatment of breast and lung cancer. Furthermore, this compound has been found to have beneficial effects on cardiovascular health, including reducing blood pressure and improving lipid metabolism.

Potential Effects of Isoimperatorin

The potential effects of isoimperatorin are wide-ranging and depend on the specific physiological process being targeted. Studies have suggested that this compound may have the following effects:

  1. Anti-inflammatory: Isoimperatorin has been found to reduce inflammation by suppressing pro-inflammatory cytokines and enzymes in the body.

  2. Antioxidant: This compound has antioxidant properties, which can help protect against oxidative stress and damage caused by free radicals.

  3. Neuroprotective: Isoimperatorin has been investigated for its potential neuroprotective properties, as it may help prevent or slow down the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.

  4. Anti-cancer: Studies suggest that isoimperatorin may have anti-cancer properties, particularly in the treatment of breast and lung cancer.

  5. Cardiovascular health: Isoimperatorin has been found to have beneficial effects on cardiovascular health, including reducing blood pressure and improving lipid metabolism.

Product Mechanism

Isoimperatorin works through various mechanisms depending on the specific health benefit being targeted. For example, its anti-inflammatory properties are thought to be due to its ability to suppress pro-inflammatory cytokines and enzymes such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).

Similarly, its antioxidant properties are thought to be due to its ability to scavenge free radicals and reduce oxidative stress. Isoimperatorin's neuroprotective properties may be due to its ability to inhibit acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine, which is important for memory and cognitive function.

Safety

Currently, there is limited information available regarding the safety of isoimperatorin in humans. However, studies conducted in animals have not revealed any significant adverse effects associated with its use. As with any new therapeutic agent, further research is needed to fully understand its safety profile in humans.

Side Effects

There have been no reported side effects associated with isoimperatorin in animal studies. However, due to the lack of human data, it is unclear whether this compound may cause any adverse effects in humans.

Dosing Information

The optimal dose of isoimperatorin has not been established. However, animal studies suggest that doses ranging from 50 to 200 mg/kg may be effective in producing its health benefits.

Conclusion

Overall, isoimperatorin is a natural coumarin derivative that has been traditionally used for its medicinal properties in China, Korea, and Japan. While it is primarily used in research, it has shown potential as a therapeutic agent for a variety of health conditions, including inflammation, oxidative stress, neurodegenerative diseases, cancer, and cardiovascular health.

However, more research is needed to fully understand the mechanisms by which isoimperatorin

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code